![Peter David Suzdak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter David Suzdak
Directeur/Bestuurslid bij Acidophil LLC
Actieve functies van Peter David Suzdak
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Acidophil LLC
![]() Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Directeur/Bestuurslid | - | - |
Loopbaan van Peter David Suzdak
Eerdere bekende functies van Peter David Suzdak
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
REXAHN PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-06-2013 | 14-11-2018 |
Algemeen Directeur | 31-01-2013 | 14-11-2018 | |
AEOLUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-06-2004 | 08-05-2013 |
Independent Dir/Board Member | 23-05-2011 | 08-05-2013 | |
Incara Pharmaceuticals Corp. | Directeur/Bestuurslid | - | 09-08-2004 |
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | 01-01-2002 |
NOVO NORDISK A/S | Hoofd Techniek/Wetenschap/O&O | 01-01-1995 | 01-01-1995 |
National Institute of Mental Health | Hoofd Techniek/Wetenschap/O&O | 01-01-1988 | 01-01-1988 |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Hoofd Techniek/Wetenschap/O&O | 23-05-2011 | - |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Algemeen Directeur | 01-01-2006 | - |
Oprichter | 31-12-2010 | - | |
President | 31-12-2010 | - | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | - | - |
Opleiding van Peter David Suzdak
University of Connecticut | Doctorate Degree |
St. John's University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 12 |
Denemarken | 2 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Chief Executive Officer | 3 |
Sectoraal
Health Technology | 9 |
Consumer Services | 3 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AEOLUS PHARMACEUTICALS, INC. | Health Technology |
NOVO NORDISK A/S | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Incara Pharmaceuticals Corp. | Health Technology |
Artesian Therapeutics, Inc.
![]() Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Corridor Pharmaceuticals, Inc.
![]() Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
National Institute of Mental Health | Government |
Guilford Pharmaceuticals, Inc.
![]() Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Rexahn Pharmaceuticals, Inc.
![]() Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Acidophil LLC
![]() Acidophil LLC Medical/Nursing ServicesHealth Services Acidophil LLC develops biotechnologies and products in the field of applied genetics and molecular engineering. It uses synthetic biology and/or synthetic chemistry to apply the lessons of evolution to the discovery and development of novel bioactive compounds and related production processes for a variety of market sectors. The company was founded by Sydney Brenner and Philip Goelet and is headquartered in Lutherville, MD. | Health Services |
- Beurs
- Insiders
- Peter David Suzdak
- Ervaring